Jan 17, 2025 · Mifeprex (mifepristone) and its generic, Mifepristone Tablets, 200 mg (collectively mifepristone) are approved, in a regimen with misoprostol, to end an intrauterine pregnancy through ten...

FDA approved a generic version of Mifeprex, Mifepristone Tablets, 200 mg, in April 2019. The agency’s approval of this generic reflects the FDA’s determination that Mifepristone...

Mifeprex (MIF-eh-prex) (mifepristone) tablets, for oral use Read this information carefully before taking Mifeprex and misoprostol. It will help you understand how the treatment works.

On January 3, 2023, updates to the U.S. Food and Drug Administration (FDA) risk evaluation and mitigation strategy (REMS) for mifepristone for reproductive health indications went into effect.

Mifeprex tablets each contain 200 mg of mifepristone, a synthetic steroid with antiprogestational effects. The tablets are light yellow in color, cylindrical and biconvex, and are intended for...

Apr 14, 2023 · When a federal judge in Texas ruled that the Food and Drug administration shouldn't have approved the abortion pill mifepristone in 2000, he agreed with arguments by plaintiffs who oppose...

Mifepristone is a progestin antagonist indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy (IUP) through 70 days gestation. Mifepristone is available...

On January 3, 2023, the FDA issued a final decision on its risk evaluation and mitigation strategy (REMS) for mifepristone, which is part of the recommended regimen for medication abortion and miscarriage management.

Jun 14, 2024 · As of December 2022, the FDA estimated that nearly 6 million women in the U.S. had used mifepristone. In 22 years of use, the agency recorded 32 deaths related to it, including its use in two...

Korlym (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes...